Clinical trials
Terminated Heart Failure trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
399 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 3 |
| 2003 | 8 |
| 2004 | 11 |
| 2005 | 12 |
| 2006 | 16 |
| 2007 | 21 |
| 2008 | 17 |
| 2009 | 21 |
| 2010 | 17 |
| 2011 | 28 |
| 2012 | 19 |
| 2013 | 23 |
| 2014 | 20 |
| 2015 | 26 |
| 2016 | 19 |
| 2017 | 16 |
| 2018 | 25 |
| 2019 | 21 |
| 2020 | 22 |
| 2021 | 12 |
| 2022 | 16 |
| 2023 | 11 |
| 2024 | 7 |
| 2025 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 399 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Medtronic Cardiac Rhythm and Heart Failure | 13 |
| Abbott Medical Devices | 8 |
| Boston Scientific Corporation | 8 |
| CardioKinetix, Inc | 6 |
| Duke University | 6 |
| Mayo Clinic | 6 |
| The Cleveland Clinic | 6 |
| AstraZeneca | 5 |
| Columbia University | 5 |
| Emory University | 5 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Heart Failure | 399 |
| Heart Diseases | 21 |
| Cardiovascular Diseases | 18 |
| Atrial Fibrillation | 16 |
| Myocardial Infarction | 16 |
| Renal Insufficiency | 13 |
| Cardiomyopathies | 12 |
| Sleep Apnea Syndromes | 9 |
| Heart Failure, Systolic | 8 |
| Hypertension | 8 |
Trials
Showing 26 to 50 of 399. Each trial links to its page on Pharma Observatory.
299 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.